Aripiprazole Early Notification (Provisional)
New listing in both the Pharmaceutical Schedule Section B and Section H (HML) from 1 April 2018. (pending Medsafe approval which was given 22 February 2018)
Aripiprazole Sandoz Tab 10 mg 30 Pharmacode TBA Schedule price $17.50
Aripiprazole Sandoz Tab 15 mg 30 Pharmacode TBA Schedule price $17.50
Aripiprazole Sandoz Tab 20 mg 30 Pharmacode TBA Schedule price $17.50
Aripiprazole Sandoz Tab 30 mg 30 Pharmacode TBA Schedule price $17.50
Reference pricing will apply to Abilify (except 5 mg ) from 1 June 2018 with delisting from HML 1 June 2018 and Pharmaceutical Schedule 1 September 2018
Further information is available on our website under Pharmac Changes.
As of the date of this notification ProPharma / PWR cannot accept Abilify for credit under any circumstances.
Click here – Consent to the Distribution of Aripiprazole in New Zealand
Aripiprazole Sandoz Tab 5 mg 30 will be listed 1 September 2018 (pending Medsafe approval, which was granted 22 February 2018)
Please note this is a moving target until PHARMAC confirm listing, Reference Pricing and Sole Supply dates.
We have put this in place to try and keep you well informed due to the significance of the price drop.
If you get caught with stock it will be costly, so I strongly suggest you buy hand to mouth until all details are finalised.